| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 01/26/2006 | US20060019974 4-Amino-quinazolines |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019336 Factor VII or VIIa - like molecules |
| 01/26/2006 | US20060018983 Composition containing green-yellow vegetables and light-colored vegetables |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | CA2572816A1 Use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a trombotic event |
| 01/26/2006 | CA2572735A1 Novel compounds that inhibit factor xa activity |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1618879A1 Injectable formulations of taxanes for cad treatment |
| 01/25/2006 | EP1618196A2 Dna-based aptamers for human cathepsin g |
| 01/25/2006 | EP1618113A1 Novel crystalline polymorphs of clopidogrel |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1617850A2 Delivery vehicle for silver ions |
| 01/25/2006 | EP1617834A1 Lactate containing pharmaceutical composition and uses thereof |
| 01/25/2006 | EP1144000B1 New dialysis method |
| 01/25/2006 | EP0914158B2 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 01/25/2006 | EP0869788B1 Compositions for the treatment of renal failure, comprising l-carnosine |
| 01/25/2006 | CN1726029A Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/25/2006 | CN1724564A Primary structure of snake origin deintegration element mutant anti human platelet aggregation medicine health beneficial protein |
| 01/25/2006 | CN1724561A Series peptide for promoting proliferation of bone marrow karyota and bone marrow substrate cell and its application |
| 01/25/2006 | CN1724031A Medicine for treating rhomboembolia type angiitis |
| 01/25/2006 | CN1724022A Compound traditional Chinese medicinal prepn. for preventing and treating uterus abnormal bleeding disease, and its prepn. method |
| 01/25/2006 | CN1724005A Method for extracting volatile oil and liposoluble alkaloid from plumula nelumbini |
| 01/25/2006 | CN1724000A Injection for treating cardiovascular and cerebrovascular diseases, and its prepn. method |
| 01/25/2006 | CN1723971A Effervescent tables for treating thrombus, and its prepn. method |
| 01/25/2006 | CN1723933A Traditional Chinese medicine capsule for treating application, and its prodn. method |
| 01/25/2006 | CN1723923A Method for extracting clerodendranthus spicatus |
| 01/25/2006 | CN1723918A Enteric coatel tables contg. donkey-hide gelatin, and its prepn. method |
| 01/25/2006 | CN1723908A Gelatin micro-particles carried with dichloromethylene diphosphonate, and its prepn. method |
| 01/25/2006 | CN1723888A Medicine with function of increasing whole blood |
| 01/25/2006 | CN1723885A Injectable diacetylamino acetic ethylenediamine prepn. preparing method and quality-control tech. therefor |
| 01/25/2006 | CN1723879A Application of schisanhenol for preparing medicine for treating ischemic brain apoplexy |
| 01/25/2006 | CN1238363C Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 01/25/2006 | CN1238051C Chinese patent medicine for treating vaginal bleeding after medicinal abortion operation and its preparation method |
| 01/25/2006 | CN1238038C Medicine for tonifying kidney, strengthening spleen, replenishing esseuce and invigorating marrow and its preparing method |
| 01/25/2006 | CN1237972C Active component of muskrat fragrant, preparing technique and usage |
| 01/25/2006 | CN1237960C Preparation method of aspirin microsphere |
| 01/24/2006 | US6989397 Iron chelators and uses thereof |
| 01/24/2006 | US6989159 Pharmaceutical compositions containing lithium carbonate |
| 01/24/2006 | CA2368431C Melanocortin receptor ligands |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060014734 Immediate release pharmaceutical formulation |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014722 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions |
| 01/19/2006 | US20060014718 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | US20060014699 Aqueous pharmaceutical formulaton comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism |
| 01/19/2006 | US20060014693 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 01/19/2006 | US20060014683 Procoagulant protein comprising polypeptide with amino acid substitutions; resistant to activated protein C; von Willebrand factor binding site deleted and thrombin cleavage site is mutated; treating hemophilia |
| 01/19/2006 | US20060014671 Hemoglobin solution packaged in an oxygen and water vapor impermeable flexible container with a multi-layer film having at least a product contact layer, an oxygen and moisture barrier layer and an exterior layer for storage and preservation of deoxygenated hemoglobin solution |
| 01/19/2006 | US20060014665 Therapeutic agent |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | US20060013852 Use of organic compounds |
| 01/19/2006 | US20060013812 Mixture comprising blood coagulation factor and serpin for use in prevention and treatment of blood disorders |
| 01/19/2006 | US20060013805 Transgenic circulating endothelial cells |
| 01/19/2006 | CA2572815A1 Combination therapies employing nicotinic acid derivatives or fibric acid derivatives |
| 01/18/2006 | EP1616880A1 Ligand having agonistic activity to mutated receptor |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616873A1 Lipid-regulating agent and use thereof |
| 01/18/2006 | EP1616869A1 Substituted porphyrins and their therapeutic use |
| 01/18/2006 | EP1615884A1 Process for the preparation of amorphous calcium salt of atorvastatin |
| 01/18/2006 | EP1615612A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 01/18/2006 | EP1539816B1 Thrombin-cleavable factor x analogues |
| 01/18/2006 | EP1463799A4 Methods for the induction of professional and cytokine-producing regulatory cells |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1213965B1 Thrombopoietin mimetics |
| 01/18/2006 | EP1200115B9 Multi-dose erythropoietin formulations |
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1723201A Blood-brain barrier disruption inhibitors |
| 01/18/2006 | CN1723035A Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 01/18/2006 | CN1723016A Composition functioning to prevent or mitigate symptom or disease attributable to blood vessel aging |
| 01/18/2006 | CN1721445A Degraded TPO agonist antibody |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1720991A Degraded agonist antibody |
| 01/18/2006 | CN1720990A Degraded agonist antibody |
| 01/18/2006 | CN1720988A Thrombus eliminating, channel activating soft capsule and its preparation method |
| 01/18/2006 | CN1720977A Female nutritive tonic capsule |
| 01/18/2006 | CN1720974A Chinese medicinal composition for treating ascites due to cirrhosis |
| 01/18/2006 | CN1720940A Fresh ganoderma lucidum region divided extractives and extraction method |
| 01/18/2006 | CN1720923A Medicine for treating cerebrovascular diseases |
| 01/18/2006 | CN1720908A Beta-Asarone transdermal plaster |
| 01/18/2006 | CN1720904A Hemodilution facilitated by monitoring oxygenation status |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/18/2006 | CN1237073C Gene configuration, preparing process and usage of antibacterial peptide |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1236831C Compositions for protein delivery via the pulmonary route |
| 01/18/2006 | CN1236792C Brain active effect matter for prevention and treating encephalopathy and developing intelligence and its preparation method |
| 01/18/2006 | CN1236778C New ass hide gelatin preparation and its preparation process |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987113 3-hetero-arylideneazaindolin-2-one compounds |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987102 Methods to mobilize progenitor/stem cells |